Suchergebnisse - "Daratumumab"

PubPharm (307)

1

Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation

enthalten in: Cytotherapy | 2024

von Major-Monfried, H. | Hosszu, K. | McAvoy, D. | +12

2

Daratumumab and antineoplastic therapy versus antineoplastic therapy only for adults with newly diagnosed multiple myeloma ineligible for transplant

enthalten in: The Cochrane database of systematic reviews | 2024

von Langer, P. | John, L. | Monsef, I. | +3

3

Clinical outcomes of pomalidomide-based and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma : A real-world cohort study in China

enthalten in: Cancer medicine | 2024

von Han, X. | Jiang, X. | He, J. | +10

4

CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Sharma, A. | Gupta, K. | Mishra, A. | +9

UpdateOf: bioRxiv. 2023 Oct 31;:. - PMID 37214794

5

Daratumumab-based quadruplet therapy for transplant-eligible newly diagnosed multiple myeloma with high cytogenetic risk

enthalten in: Blood cancer journal | 2024

von Callander, N. | Silbermann, R. | Kaufman, J. | +33

6

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

7

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

enthalten in: Cancer biology & therapy | 2024

von Wang, H. | Koob, T. | Fromm, J. | +3

8

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes : resetting synergistic activity

enthalten in: Blood cancer journal | 2024

von Kostopoulos, I. | Fotiou, D. | Gavriatopoulou, M. | +14

9

Daratumumab for patients with myeloma with early or late relapse after initial therapy : subgroup analysis of CASTOR and POLLUX

enthalten in: Blood advances | 2024

von Spencer, A. | Moreau, P. | Mateos, M. | +17

10

Designing combination therapies for cancer treatment : application of a mathematical framework combining CAR T-cell immunotherapy and targeted radionuclide therapy

enthalten in: Frontiers in immunology | 2024

von Adhikarla, V. | Awuah, D. | Caserta, E. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]